DOH: Solidarity Trial of hydroxychloroquine continues; says WHO stopped only new allocations for drug use
  • 4 years ago
The Department of Health (DOH) on Wednesday clarified that patients who were already given the anti-malarial drug hydroxychloroquine, in the ongoing Solidarity Trial of the World Health Organization, will still continue to undergo the said treatment scheme, a day after it announced that they will stop using the said drug.

READ: https://bit.ly/2TKjrj1
Recommended